ENA Sectors 2025-06-12 14:17:30 <p><span style="font-size:14px"><strong>New Delhi, Jun 12 (KNN)</strong> Deeptech start-up Leumas has completed a USD 2.2 million seed funding round led by Capital 2B, with participation from Capital-A and Anicut Capital.</span></p> <p><span style="font-size:14px">The company specialises in developing manufacturing solutions for pharmaceutical and wellness sectors through AI-driven robotic systems.</span></p> <p><span style="font-size:14px">The funding will enable Leumas to advance the development and deployment of its modular robot factories, which utilise artificial intelligence to adapt production processes across different formulations and manufacturing volumes.</span></p> <p><span style="font-size:14px">The technology is designed to enhance traceability, operational responsiveness, and cost efficiency within manufacturing environments.</span></p> <p><span style="font-size:14px">Co-founders Subhajit Biswas and Nitesh K emphasised the industry's need for manufacturing flexibility beyond traditional capacity expansion.</span></p> <p><span style="font-size:14px">They described their approach as creating a manufacturing infrastructure that operates with software-like characteristics, incorporating modularity, distributed processing, and intelligent automation systems.</span></p> <p><span style="font-size:14px">Leumas is targeting opportunities within the global outsourced manufacturing market, which industry projections indicate may surpass USD 400 billion by 2030.</span></p> <p><span style="font-size:14px">The company identifies growing demand for on-demand and personalised production in wellness and pharmaceutical sectors as driving factors that expose limitations in conventional factory operations.</span></p> <p><span style="font-size:14px">The company's platform combines AI-based robotics with vision-guided quality control systems and autonomous manufacturing processes to enable unmanned, traceable production capabilities.</span></p> <p><span style="font-size:14px">Leumas reports having collaborated with wellness brands to scale more than 120 products across markets in India, the United States, and the Middle East and North Africa region.</span></p> <p><span style="font-size:14px">The start-up has also established partnerships with pharmaceutical and food research institutions to conduct pilot manufacturing projects, demonstrating practical applications of its technology platform.</span></p> <p><span style="font-size:14px">Vibhore Sharma, Partner at lead investor Capital 2B, characterised the company as addressing manufacturing challenges related to speed, cost, and scalability.</span></p> <p><span style="font-size:14px">Sharma highlighted the integration of advanced robotics with intelligent software systems and the accessibility of Leumas's delivery model for brand adoption.</span></p> <p><span style="font-size:14px">Ankit Kedia, Founder of participating investor Capital-A, noted the combination of technical expertise and operational execution demonstrated by Leumas, particularly relevant for industries requiring speed, regulatory compliance, and operational adaptability.</span></p> <p><span style="font-size:14px">Ajay Anand, Partner, Anicut Capital, described Leumas as representing future manufacturing paradigms characterised by modularity, intelligence, and rapid scalability capabilities.</span></p> <p><em><strong><span style="font-size:14px">(KNN Bureau)</span></strong></em></p> 42417 https://knnindia.co.in/news/newsdetails/sectors/ai-powered-deeptech-start-up-leumas-secures-usd-22-mn-seed-funding 2025-06-12 14:17:30 knnindia.co.in